Oxford Instruments plc

Oxford Instruments plc

OXINF
Oxford Instruments plcUS flagOther OTC
43.80
USD
- -
- -
2.42BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
6.24
6.34
6.66
5.6
5.26
5.19
5.49
5.53
5.55
6.39
7.71
8.14
8.63
Basic EPS, GAAP
0.37
0.32
-0.11
0.12
-0.36
1.15
0.52
0.59
0.73
0.67
1.02
0.88
0.45
Free Cash Flow per Basic Share
0.5
0.25
0.34
0.56
0.53
0.45
0.65
0.89
0.66
0.61
0.59
0.27
0.6
Dividend per Share
0.1
0.11
0.12
0.13
0.13
0.13
0.13
0.14
- -
0.21
0.18
0.2
0.21
Book Value per Share
1.3
1.46
1.07
1.26
0.84
1.9
2.22
3.1
3.43
4.28
4.65
5.11
5.31
Tangible Book Value per Share
0.81
-1.9
-1.85
-1.36
-0.85
0.37
0.87
2.02
2.5
3.06
3.67
3.94
4.38
Basic Weighted Avg Shares
56
57
57
57
57
57
57
57
57
58
58
58
58
Sales/Revenue/Turnover
351
360
380
320
300
297
314
317
318
367
445
470
501
Operating Margin (%)
13
12.44
10.5
12.42
16.92
12.23
12.61
15.56
17.52
13.26
16.91
14.82
16.48
Depreciation Expense
22
24
32
26
55
20
18
19
18
19
20
20
22
Net Income, GAAP
21
18
-6
7
-20
66
30
34
42
39
59
51
26
Effective Tax Rate (%)
26.06
24.17
- -
27.84
- -
42.69
18.95
17.53
19.92
18.91
20.27
28.89
34.67
Profit Margin (%)
5.99
5.05
-1.66
2.19
-6.76
22.06
9.55
10.65
13.12
10.51
13.18
10.78
5.19
Working Capital
53
60
46
39
46
42
44
57
95
93
116
126
148
LT Debt
- -
141
144
147
130
39
34
6
5
16
27
30
27
Total Equity
138
140
126
143
132
180
202
252
266
316
344
366
376
Return on Invested Capital (%)
24.32
15.24
- -
10.08
- -
8.27
13.61
14.5
14.19
11.91
15.99
12.06
12.72
Return on Capital (%)
31.98
12.59
- -
3.86
- -
40.84
20.44
17.32
18.31
15.52
20.39
15.85
7.9
Return on Common Equity (%)
30.17
23.3
-8.74
10.56
-33.92
83.71
25.49
22.19
22.31
17.42
22.78
17.99
8.62

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.17%
8.51%
2.84%
Free Cash Flow
16.09%
7.03%
125.32%
Net Income, GAAP
-105.97%
1.12%
-48.72%
Sales/Revenue/Turnover
3.27%
9.79%
6.42%
Total Cash Common Dividend
- -
- -
6.14%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
470
2025
- -
- -
- -
- -
501
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.88
2025
- -
- -
- -
- -
0.45
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.2
2025
- -
- -
- -
- -
0.21
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Richard Tyson
Full Time Employees
2,000
Sector
Technology
Industry
Semiconductors
Address
Tubney Woods Abingdon United Kingdom OX13 5QX
IPO Date
Feb 17, 2011
Website
oxinst.com
Business
Oxford Instruments plc designs and manufactures high technology tools and systems that enable the fabrication, analysis, and manipulation of matter at the atomic and molecular level for research and industrial applications; headquartered in Abingdon, Oxfordshire, England, with operations across the United Kingdom, United States, Europe, Asia, and other regions, the company was founded in 1959 as the first substantial commercial spin-out from the University of Oxford and lists on the London Stock Exchange (ticker: OXIG) as a FTSE 250 constituent. Operating through two primary divisions—Imaging & Analysis and Advanced Technologies—it serves sectors including materials & characterisation, research & discovery, semiconductors, healthcare & life sciences, quantum technologies, and industrial applications, targeting academic institutions, government laboratories, and commercial customers in nanotechnology, advanced materials, compound semiconductors, and clean energy. Core products encompass deposition tools such as plasma enhanced chemical vapour deposition (PECVD), inductively coupled plasma chemical vapour deposition (ICPCVD), atomic layer deposition (ALD), and ion beam deposition (IBD); etch tools including inductively coupled plasma etching (ICP RIE), reactive ion etching (RIE), deep silicon etching (DSiE), atomic layer etching (ALE), and ion beam etching (IBE); cryogenic systems and dilution refrigerators like the Proteox suite; benchtop NMR, microanalysis and electron backscatter diffraction (EBSD) detectors, X-ray fluorescence and optical emission spectrometers, coating thickness gauges, MRI and CT systems, low temperature high magnetic field systems, X-ray tubes, plasma processing equipment, VCSELs, atomic force microscopy (AFM), Raman imaging microscopes via WITec, scientific cameras and spectrometers from Andor Technology, scanning probe microscopes from Asylum Research, and nanoindentation instruments from FemtoTools. Recent developments include the completion of the acquisition of FemtoTools AG in July 2024 for £15.8 million, integrating its MEMS-based nanoindentation technology into the Imaging & Analysis division to enhance materials hardness and stiffness measurement capabilities for semiconductor and research uses; relocation to the new state-of-the-art Severn Beach facility, tripling compound semiconductor processing capacity for datacomms, AI datacentres, power electronics, and augmented reality applications with strong double-digit order growth; and an ongoing operational transformation programme across sites like Belfast's Imaging & Analysis facility, Oxfordshire's quantum operations, and Ulm's Raman facility in Germany, introducing lean processes, improved quality, reduced lead times, and productivity enhancements. In June 2025, the company agreed to divest its quantum-focused subsidiary NanoScience for £60 million amid strategic streamlining efforts. Half-year results for FY26 reflect challenging Q1 trading offset by positive H2 momentum, particularly in compound semiconductors, aligning with full-year expectations.

Company News

APIChat
  • Oxford Instruments (OTCMKTS:OXINF) Shares Gap Down – Here’s What Happened

  • Oxford Instruments plc (OXINF) Q2 2026 Earnings Call Transcript

  • Oxford Instruments buoyed by recovering orders and cost discipline

  • Oxford Instruments shares slide 14% as tariffs weigh on first-half sales

  • Oxford Instruments sells quantum business for £60m

  • Oxford Instruments Asylum Research Releases New Vero VRS1250 Atomic Force Microscope

  • Oxford Instruments Asylum Research Receives R&D 100 and Frost & Sullivan Awards for its Vero Atomic Force Microscope

  • Oxford Instruments rally continues on split plans

  • Powerful AFM Offline Analysis Software Now Available for Oxford Instruments Asylum Research Jupiter XR Large-Sample Atomic Force Microscope

  • Oxford Instruments Asylum Research releases VERO, an Interferometric AFM

  • New Strong Sell Stocks for October 23rd

  • Oxford Instruments slips on lower-end profit expectations

  • Oxford Instruments reports growth in revenues and orders at half-way stage

  • Oxford Instruments reports order growth but says supply chain issues remain

  • Oxford Instruments profits rise on strong orders; supply chain disruption affecting order conversion